MIR3197: A Potential Drug Target and Biomarker for Obesity (G100423023)
MIR3197: A Potential Drug Target and Biomarker for Obesity
Obesity has become a significant public health issue, with an estimated 285 million people worldwide classified as obese. The increasing prevalence of obesity is due to various factors, including changes in diet, lack of physical activity, and genetic factors. Obesity is not only associated with various health conditions, such as cardiovascular disease, diabetes, and certain cancers, but it also contributes to various non-communicable diseases, including diabetes, hypertension, and certain cancers. Therefore, identifying potential drug targets and biomarkers for obesity is crucial for developing effective therapies. In this article, we will discuss MIR3197, a potential drug target and biomarker for obesity.
MIR3197 is a gene that encodes a protein named MIR3197. MIR3197 is expressed in various tissues and cells in the body, including adipose tissue, muscle tissue, and the liver. It is a 21-kDa protein that consists of 116 amino acid residues. MIR3197 is involved in various cellular processes, including cell signaling, DNA replication, and metabolism.
Research has shown that MIR3197 is involved in the regulation of obesity-related genes and signaling pathways. MIR3197 has been shown to play a role in the development of obesity by modulating the activities of genes involved in energy metabolism, inflammation, and cellular signaling. For example, MIR3197 has been shown to inhibit the activity of the gene PPAR未, which is involved in glucose metabolism and energy homeostasis. PPAR未 is a key regulator of obesity, and MIR3197 has been shown to inhibit its activity, leading to increased energy intake and obesity.
In addition to its role in obesity, MIR3197 has also been shown to play a role in cancer development. MIR3197 has been shown to promote the growth and metastasis of various cancer types, including colon cancer, breast cancer, and melanoma. Therefore, MIR3197 is a potential drug target for cancer therapies.
MIR3197 has also been shown to play a role in inflammation. Obesity is associated with an increased risk of inflammation throughout the body. MIR3197 has been shown to contribute to inflammation by modulating the activities of immune cells and promoting the production of pro-inflammatory cytokines. This contributes to the development of various inflammatory diseases, including obesity-related diseases and chronic obstructive pulmonary disease (COPD).
In conclusion, MIR3197 is a potential drug target and biomarker for obesity. Its role in energy metabolism, inflammation, and cellular signaling makes it an attractive target for therapies aimed at reducing obesity. Further research is needed to fully understand the role of MIR3197 in obesity and to develop effective therapies.
Protein Name: MicroRNA 3197
The "MIR3197 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3197 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682
